Research Paper Volume 15, Issue 1 pp 119—133
Profiling of a novel circadian clock-related prognostic signature and its role in immune function and response to molecular targeted therapy in pancreatic cancer
Figure 1. Development of a circadian clock-related prognostic signature. (A) Forest plot for 27 genes with a statistical relevance. (B, C) The 27 qualified genes were subsequently fed into LASSO regression model.